10-OH-HHCP (10-Hydroxy-Hexahydrocannabiphorol) – Advanced Cannabinoid Analog
Molecular Formula: C₂₃H₃₆O₂
Classification: Semi-synthetic cannabinoid; hydrogenated phytocannabinoid analog
CAS Number: [Pending]
Description:
10-OH-HHCP is a hydroxylated derivative of hexahydrocannabiphorol (HHCP), featuring a hydroxyl (-OH) group substitution at the C10 position on the cyclohexyl ring. This structural modification is hypothesized to enhance both CB₁ receptor affinity and lipophilicity, potentially leading to a more prolonged and bioavailable effect profile compared to HHCP and other hydrogenated cannabinoids.
Physicochemical Properties:
Appearance: Amber to golden viscous oil
Purity: ≥95% (HPLC verified)
Solubility: Lipid-soluble; miscible with oils and non-polar solvents
Stability: Stable under standard storage conditions; protect from light and air
Pharmacological Profile (Preliminary):
Although formal studies are limited, anecdotal and early user feedback suggest that 10-OH-HHCP may exhibit:
High CB₁ agonist activity (greater than HHCP)
Delayed onset with extended duration of psychoactivity
Intense euphoria and strong sedative/body-load effects
Recommended Applications:
Research and analytical use
Advanced product formulations (vape cartridges, tinctures, concentrates)
Not recommended for inexperienced users due to elevated potency
Disclaimer:
This compound is intended strictly for laboratory research or industrial processing. Not approved for therapeutic, diagnostic, or recreational use. Ensure compliance with all local regulations before purchase or use.